109 LONG TERM EFFICACY AND SURVIVAL IN PATIENTS TREATED WITH THE GUT-SELECTIVE ANTIBIOTIC RIFAXIMIN (550 MG BID) FOR THE MAINTENANCE OF REMISSION FROM OVERT HEPATIC ENCEPHALOPATHY

✍ Scribed by K.D. Mullen; F. Poordad; L. Rossaro; M. Jamal; J. Talwalkar; S. Huang; K. Merchant; E. Bortey; W.P. Forbes

• Book ID: 117379255
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 42 KB
• Volume: 54
• Category: Article
• ISSN: 0168-8278
• DOI: 10.1016/s0168-8278(11)60111-6